Tilray Brands, Inc
Tilray Inc. produces and distributes medical and adult-use cannabis products.
Stock Performance Snapshot
Analyst Rating
Analysts suggest maintaining current Tilray stock holdings with a target price of $1.87, indicating slight growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring TLRY
Vice Arbitrage
Get exposure to companies leading the transformation of once-prohibited activities into booming legal industries. These carefully selected stocks represent market leaders capitalizing on shifting regulations in sports betting, cannabis, and more, unlocking tremendous growth potential.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Growth and Scale
Tilray is building brands and distribution globally, which could support revenue growth, though execution and margin improvement are not guaranteed.
Regulatory Impact
Changes in cannabis laws and licensing shape Tilray's addressable markets; regulatory shifts can create opportunity but also add uncertainty.
International Footprint
A diversified presence across markets spreads exposure beyond one geography, yet cross‑border rules and local competition add complexity and risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
